A TElmisartan and AMlodipine STudy to Assess the Cardiovascular PROTECTive Effects as Measured by Endothelial Dysfunction in Hypertensive at Risk Patients Beyond Blood Pressure.
Phase of Trial: Phase IV
Latest Information Update: 01 Dec 2017
At a glance
- Drugs Amlodipine (Primary) ; Telmisartan (Primary) ; Hydrochlorothiazide; Olmesartan medoxomil
- Indications Hypertension
- Focus Pharmacodynamics
- Acronyms TEAMSTA PROTECT I; TEAMSTAprotect
- 01 Dec 2017 Results published in the Clinical Chemistry
- 11 Jul 2011 Planned end date changed from 1 Aug 2011 to 1 Oct 2011 as reported by ClinicalTrials.gov.
- 11 Jul 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.